中性粒细胞减少时肺修复受损可通过基质金属蛋白酶-9逆转
该研究在小鼠 ventilator induced lung injury(VILI)模型中证实,损伤后中性粒细胞减少会延迟肺修复,表现为促炎因子升高和 MMP-9 缺失。中性粒细胞减少的 ARDS 患者 BALF 呈现相似改变,且体外上皮伤口闭合延迟,去除胶原或添加外源性 MMP-9 可改善。外源性 MMP-9 治疗中性粒细胞减少小鼠可减轻组织损伤而不改变细胞因子浓度。
要点
- 中性粒细胞来源的 MMP-9 是肺损伤后基质加工与修复的必要条件。
- 中性粒细胞减少时肺内 TNF-α、IFN-γ 和 MIP-2 升高且 MMP-9 缺失。
- 外源性 MMP-9 可减轻中性粒细胞减少小鼠 VILI 后的组织损伤。
核心结论
- 中性粒细胞释放 MMP-9 是充分基质加工和肺修复所必需的。
研究设计与样本
- 小鼠 VILI 后诱导中性粒细胞减少并自主呼吸观察 48 小时,检测肺组织炎症介质和基质金属蛋白酶。
- 收集伴或不伴中性粒细胞减少的机械通气 ARDS 患者 BALF,检测相同介质并在体外肺泡修复模型中研究其效应。
- 对 VILI 后中性粒细胞减少小鼠给予外源性 MMP-9 治疗。
主要发现
- 中性粒细胞减少小鼠肺修复延迟,TNF-α、IFN-γ 和 MIP-2 水平升高,MMP-9 缺失。
- 中性粒细胞减少的机械通气 ARDS 患者 BALF 显示相似结果。
- 中性粒细胞减少患者 BALF 在体外导致上皮伤口闭合率延迟,去除胶原或添加外源性 MMP-9 可改善。
- 外源性 MMP-9 治疗中性粒细胞减少小鼠可减少组织损伤,而不改变细胞因子浓度。
临床怎么用
- 呼吸科医生应认识到中性粒细胞减少患者的肺修复障碍可能与 MMP-9 缺乏相关。
- 对中性粒细胞减少合并肺损伤患者,需关注基质加工受损对修复的影响。
- 外源性 MMP-9 可能是改善中性粒细胞减少状态下肺修复的潜在策略,但尚未进入临床推荐。
局限性
- 主要证据来自小鼠 VILI 模型和体外实验,临床转化需进一步验证。
- 中性粒细胞减少患者 BALF 样本量及具体临床特征未在摘要中报告。
- 外源性 MMP-9 治疗的长期安全性和有效性未评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neutrophils may cause tissue disruption during migration and by releasing cytotoxic molecules. However, the benefits of neutrophil depletion observed in experimental models of lung injury do not correspond with the poor outcome of neutropenic patients. METHODS: To clarify the role of neutrophils during repair, mice with ventilator induced lung injury (VILI) were rendered neutropenic after damage, and followed for 48 hours of spontaneous breathing. Lungs were harvested and inflammatory mediators and matrix metalloproteinases measured. Bronchoalveolar lavage fluid (BALF) from ventilated patients with acute respiratory distress syndrome, with or without neutropenia, was collected, the same mediators measured and their effects in an ex vivo model of alveolar repair studied. Finally, neutropenic mice were treated after VILI with exogenous matrix metalloproteinase-9 (MMP-9). RESULTS: Lungs from neutropenic animals showed delayed repair and displayed higher levels of tumour necrosis factor α, interferon γ and macrophage inflammatory protein 2, and absence of MMP-9. BALF from ventilated neutropenic patients with acute respiratory distress syndrome showed similar results. BALFs from neutropenic patients yielded a delayed closure rate of epithelial wounds ex vivo, which was improved by removal of collagen or addition of exogenous MMP-9. Lastly, treatment of neutropenic mice with exogenous MMP-9 after VILI reduced tissue damage without modifying cytokine concentrations. CONCLUSION: Release of MMP-9 from neutrophils is required for adequate matrix processing and lung repair.
引用
- Blázquez-Prieto J, López-Alonso I, Amado-Rodríguez L, et al. Impaired lung repair during neutropenia can be reverted by matrix metalloproteinase-9. Thorax. 2017. PMID: 28947666. doi:10.1136/thoraxjnl-2017-210105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。